Administration of plasma-derived hemopexin before or during VOC in the Townes SCD mouse model, triggered either by heme or hypoxia-reoxygenation, have shown that administration of hemopexin can prevent or reduce VOC, but also, have antioxidant and anti-inflammatory effects (46, 47). This evidence concerns the gene HPX and Schnyder corneal dystrophy.